Patents

US 8940897 B2: 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors

Granted
2015-01-27
Filed
2013-03-29 application 13853452
Type
Utility · 5 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

β-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D β-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.

Source: PVGPATDIS, file of 2026-04-10 (ipg150127.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Cubist Pharmaceuticals LLC 29 patentsForeign company or organizationLexington, MACUBIST PHARMACEUTICALS INC SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Yu Gui GuActon, MA16PVGPATDIS, file of 2026-04-10
Yong HeBedford, MA76PVGPATDIS, file of 2026-04-10
Ning YinLexington, MA16PVGPATDIS, file of 2026-04-10
Dylan C. AlexanderWatertown, MA9PVGPATDIS, file of 2026-04-10
Jason CROSSActon, MA36PVGPATDIS, file of 2026-04-10
Chester A. Metcalf, IIINeedham, MA23PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/546PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/04PVGPATDIS, file of 2026-04-10
C07DHeterocyclic compoundsC07D471/08PVGPATDIS, file of 2026-04-10
Y02ATechnologies for adaptation to climate changeY02A50/30PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-08-08Merger
Merger
MERCK SHARP & DOHME CORP. signed 2022-04-07MERCK SHARP & DOHME LLC RAHWAY, NJ61102/145PASDL, file of 2026-10-15
2015-08-06Assignment
Nunc pro tunc assignment
CUBIST PHARMACEUTICALS LLC signed 2015-08-05MERCK SHARP & DOHME CORP. RAHWAY, NJ36268/626ECORSEXC, file of 2026-09-25
2015-08-05Name change
Change of name
CUBIST PHARMACEUTICALS, INC. signed 2015-06-29CUBIST PHARMACEUTICALS LLC KENILWORTH, NJ36283/189PASDL, file of 2026-10-15
2013-11-14Correction
Corrective assignment to correct the property number 61/618,131 recorded on reel 030839 frame 0569. assignor(s) hereby confirms the assignment.
ALEXANDER, DYLAN C signed 2013-04-24
BUSCH, ROBERT signed 2013-04-24
CROSS, JASON B signed 2013-04-24
GU, YU GUI signed 2013-04-24
HE, YONG signed 2013-04-24
YIN, NING signed 2013-04-24
METCALF III, CHESTER A signed 2013-04-26
CUBIST PHARMACEUTICALS, INC. LEXINGTON, MA31865/356ECORSEXC, file of 2026-09-25
2013-07-19Assignment
Assignment of assignor's interest
ALEXANDER, DYLAN C. signed 2013-04-24
BUSCH, ROBERT signed 2013-04-24
CROSS, JASON B. signed 2013-04-24
GU, YU GUI signed 2013-04-24
HE, YONG signed 2013-04-24
YIN, NING signed 2013-04-24
METCALF, CHESTER A., III signed 2013-04-26
CUBIST PHARMACEUTICALS, INC. LEXINGTON, MA30839/569ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.